Amedisys, Inc. (NASDAQ:AMED) Given Average Recommendation of “Hold” by Brokerages

Shares of Amedisys, Inc. (NASDAQ:AMED) have been given a consensus recommendation of “Hold” by the eight analysts that are currently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $97.50.

A number of research analysts recently issued reports on the company. StockNews.com upgraded Amedisys from a “hold” rating to a “buy” rating in a report on Saturday. Cantor Fitzgerald reissued a “neutral” rating and set a $101.00 target price on shares of Amedisys in a research note on Thursday, April 25th. Royal Bank of Canada upped their target price on Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, March 25th. Finally, Raymond James reiterated a “market perform” rating on shares of Amedisys in a report on Tuesday, March 26th.

Hedge Funds Weigh In On Amedisys

Institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of Amedisys by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 3,241,160 shares of the health services provider’s stock worth $302,724,000 after buying an additional 12,137 shares during the period. Alpine Associates Management Inc. increased its stake in shares of Amedisys by 23.0% during the fourth quarter. Alpine Associates Management Inc. now owns 1,271,097 shares of the health services provider’s stock valued at $120,830,000 after purchasing an additional 237,600 shares in the last quarter. Pentwater Capital Management LP lifted its holdings in shares of Amedisys by 239.5% during the third quarter. Pentwater Capital Management LP now owns 1,144,000 shares of the health services provider’s stock valued at $106,850,000 after purchasing an additional 807,000 shares during the last quarter. Westchester Capital Management LLC boosted its position in shares of Amedisys by 3.4% in the 4th quarter. Westchester Capital Management LLC now owns 879,402 shares of the health services provider’s stock worth $83,596,000 after purchasing an additional 29,016 shares in the last quarter. Finally, Park West Asset Management LLC grew its stake in shares of Amedisys by 8.0% in the 4th quarter. Park West Asset Management LLC now owns 812,069 shares of the health services provider’s stock worth $77,195,000 after buying an additional 60,350 shares during the last quarter. Institutional investors own 94.36% of the company’s stock.

Amedisys Stock Down 0.4 %

Shares of Amedisys stock opened at $92.08 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.09 and a current ratio of 1.09. Amedisys has a 52-week low of $73.10 and a 52-week high of $96.44. The company’s 50 day moving average price is $92.40 and its 200-day moving average price is $93.33. The stock has a market capitalization of $3.01 billion, a price-to-earnings ratio of -143.88, a P/E/G ratio of 3.42 and a beta of 0.84.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01. Amedisys had a negative net margin of 0.91% and a positive return on equity of 12.85%. The business had revenue of $571.41 million for the quarter, compared to analyst estimates of $565.38 million. During the same quarter last year, the firm earned $1.00 EPS. The company’s revenue was up 2.7% on a year-over-year basis. Equities research analysts forecast that Amedisys will post 4.57 EPS for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.